JPS649965B2 - - Google Patents

Info

Publication number
JPS649965B2
JPS649965B2 JP57082137A JP8213782A JPS649965B2 JP S649965 B2 JPS649965 B2 JP S649965B2 JP 57082137 A JP57082137 A JP 57082137A JP 8213782 A JP8213782 A JP 8213782A JP S649965 B2 JPS649965 B2 JP S649965B2
Authority
JP
Japan
Prior art keywords
composition
composition containing
acid
skin
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57082137A
Other languages
Japanese (ja)
Other versions
JPS58198421A (en
Inventor
Reiko Kosaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP57082137A priority Critical patent/JPS58198421A/en
Publication of JPS58198421A publication Critical patent/JPS58198421A/en
Publication of JPS649965B2 publication Critical patent/JPS649965B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は皮膚脱色及び皮膚疾患治療用組成物に
関する。 皮膚のムダ毛の漂白やシミ、ソバカス、日焼け
の防止などに用いる薬剤や組成物は従来から種々
知られている。例えば、ムダ毛の漂白には過酸化
水素水が用いられ、また、シミ、ソバカス、日焼
けの防止にはハイドロキノンなどの皮膚漂白剤、
ビタミンCやビタミンC誘導体、生薬抽出物等を
含む組成物が知られている。しかし、これらの薬
剤や組成物は皮膚に対する刺激が強いとか、逆
に、刺激が少ないものは効力の発現に長時間を要
したり、効果が不充分であるなどの欠点を有して
おり、これらを用いて、皮膚に刺激を与えずにシ
ミ、ソバカス、アザなどを除去することは困難で
ある。また、近年、化粧品による皮膚障害、とり
わけ黒皮症による黒褐色の皮膚着色が大きな問題
となつているが、かかる皮膚着色を除去すること
は非常に困難なことと考えられている。 ところが、本発明者は、驚くべきことに、還元
作用を有する含硫化合物と一定の成分を含有する
3剤型または2剤型の組成物を用いることによ
り、皮膚に対して有害な刺激を与えたり、炎症を
起こすことなく、シミやソバカスはもちろん、ア
ザや黒皮症による皮膚着色をも非常に短期間に除
去できることを見出し特許(特公昭55−44043号、
特許第1051060号)を得た。 本発明者は継続して鋭意研究を行つたところ、
上記特許の組成物に更に新たな成分を加えること
により、より一層優れた皮膚脱色効果が得られる
と共に、ニキビ、吹出物、カビ様その他の各種の
湿疹、水虫、皮膚病などの皮膚疾患の治療にも極
めて有効である組成物が得られることを見い出し
本発明を完成するに至つた。 即ち本発明は動物性肝油を含有する第1組成
物、含硫黄化合物を含有する塩基性の第4組成
物、過酸化水素及びサリチル酸を含有する第5組
成物並びに臭素酸塩を含有する酸性の第6組成物
からなることを特徴とする4剤型の、及び上記第
1組成物の次に生卵白を含有する第2組成物を用
いた5剤型の、更には該第2組成物の次に卵黄油
又はレシチン−油混合物を含有する第3組成物を
用いた6剤型の皮膚脱色及び皮膚疾患治療用組成
物に係る。 本発明においては第3組成物及び第4組成物を
予め混合熟成させて使用することも有利である。 本発明の組成物の作用機構は明らかではない
が、本発明の組成物を数回使用することにより、
皮膚に有害な刺激を与えたり、炎症を起こすこと
なく、シミ、ソバカス、アザ(特に後天的なも
の)あるいは黒皮症による皮膚着色などを除去す
ることができる。ことに、本発明の第3及び第4
組成物を予め熟成して用いた組成物は皮膚に対す
る刺激がほとんどなく、配合した含硫黄化合物の
有する特異的な臭気を完全に抑制でき、使用感が
きわめて優れている。また、本発明の組成物は皮
膚脱色効果のみならず、ニキビの防止やシワ防止
の効果も有することは勿論のこと、驚くべきこと
にニキビ、吹出物、水虫を始めとし、従来根治困
難でやつかいな病気とされていたカビ様その他の
各種の皮膚病にも極めて有効であり、皮膚疾患治
療剤としても有用である。 本発明の第1組成物の必須成分である動物性肝
油としては各種のものが使用でき、とりわけサ
メ、タラ、イカ、鯨等の魚類その他の肝臓から得
られる脂肪油が好ましい。 第2組成物の生卵白は通常好ましくは鶏の生卵
白が使用される。 第3組成物の必須成分として用いる卵黄油は、
好ましくは鶏卵の卵黄のエーテル抽出物などのよ
うな有機溶媒抽出物で、ことにエーテル抽出物が
好ましい。また、レシチン−油混合物は卵黄レシ
チンまたは大豆レシチンを大豆油、オリーブ油な
どのような植物油、好ましくは大豆油と、好まし
くはレシチン:植物油の重量比が30〜40:70〜60
となるごとく混合したものである。 これらの成分は単独で第3組成物としてもよ
い。また、所望により、さらにオリーブ油やハチ
ミツなどの他の成分を第3組成物中、最大、約50
%(重量%、以下同じ)程度まで配合してもよ
く、これにより使用感が向上する。 第4組成物の必須成分として用いる含硫黄化合
物としては、例えば、チオグリコール酸、チオ乳
酸、チオプロピオン酸、チオサリチル酸、チオ酪
酸などのごときメルカプタンの塩基性塩、好まし
くは、チオグリコール酸のアンモニウム塩、エチ
レンジアミン塩、モノエタノールアミン塩、ジエ
タノールアミン塩、トリエタノールアミン塩な
ど、重亜硫酸ナトリウムなどの重亜硫酸塩、シス
テイン(L、D、DL体を含む)などが挙げられ、
ことにチオグリコール酸アンモニウムが好まし
い。これらの含硫黄化合物は、通常、第4組成物
中約1〜10%、好ましくは、約3〜6%配合さ
れ、該第4組成物は、例えば、水酸化ナトリウ
ム、水酸化カリウム、炭酸ナトリウム、アンモニ
アなどを用いて塩基性、好ましくは、約7.5〜8.5
のPHに調整する。 第5組成物において過酸化水素は通常約1〜40
%程度、特に約3〜10%程度の水溶液として用い
るのが好ましく、オキシドールとして市販されて
いるものを使用することができる。第5組成物は
斯かる過酸化水素水にサリチル酸を通常約0.1〜
30%、好ましくは約1〜20%溶解して調整される
が、特に使用の直前に調製するのが望ましい。 第6組成物の必須成分としては臭素酸塩、例え
ば、臭素酸ナトリウムもしくはカリウムのような
臭素酸アルカリ金属塩が挙げられ、これは単独で
も混合して用いてもよく、好ましくは、臭素酸カ
リウム塩を用いる。該成分は、通常、第6組成物
中、約10%、好ましくは、約3〜6%配合され、
該第6組成物は、例えば、クエン酸、シユウ酸、
コハク酸、酢酸、安息香酸などで酸性、好ましく
は、約5.5〜6.5のPHに調整する。 また、本発明においては、前記第3組成物と第
4組成物を、例えば、重量比9〜5:1〜5の割
合で均一に混合し、これを10〜30℃、好ましく
は、室温で、1〜3日、好ましくは、約1日保持
熟成することにより、効果には全く影響を及ぼす
ことなく、含硫黄化合物の有する特異臭を抑制
し、使用感を向上させることができる。 本発明の組成物を適用する好適な1例を挙げる
と、まず第1組成物を皮膚の着色部分又は要治療
部分に塗布し、擦り込み、次に同様にして第2組
成物により処理する。その後第3組成物を塗布し
てマツサージを行い、次いで第4組成物を綿ガー
ゼ等にとり、たたくようにして塗布し、マツサー
ジを行い、数分間放置後、拭きとる。第3組成物
と第4組成物の混合物を用いた場合も、塗布後マ
ツサージを行い、その後数分放置した後、拭きと
る。次に第5組成物を塗布して、しばらく放置し
た後、最後に第6組成物で第4組成物と同様にし
て処理する。 かくして、本発明の組成物はいずれも、混合、
溶解などの通常の方法により、溶液、乳液、ゲ
ル、クリーム、エアゾールなどの剤形に処方する
ことができる。 つぎに実施例を挙げて本発明をさらに詳しく説
明する。 実施例 1 第1組成物 鮫の肝油 100% 第4組成物 チオグリコール酸アンモニウム 5% 水酸化ナトリウム PH8.0に調整 水 100%に調整 第5組成物 過酸化水素(6%) 20c.c. サリチル酸 2g 第6組成物 臭素酸カリウム 5% クエン酸 PH6.5に調整 水 100%に調整 上記各成分を使用して本発明組成物を得た。 実施例 2 第1組成物 鮫の肝油 100% 第2組成物 生卵白 100% 第4組成物 チオグリコール酸アンモニウム 3% 水酸化ナトリウム PH8.0に調整 水 100%に調整 第5組成物 過酸化水素(6%) 10c.c. サリチル酸 1.5g 第6組成物 臭素酸カリウム 3% クエン酸 PH6.5に調整 水 100%に調整 上記成分を使用して本発明組成物を得た。 実施例 3 第1組成物 鮫の肝油 100% 第2組成物 生卵白 100% 第3及び第4組成物の混合物 A 成分 大豆レシチン−大豆油(重量比1:1混合物)
85% オリーブ油 10% ハチミツ 5% B 成分 チオグリコール酸アンモニウム 5% 水酸化ナトリウム PH8.0に調整 水 100%に調整 第5組成物 過酸化水素(6%) 25c.c. サリチル酸 3g 第6組成物 臭素酸カリウム 5% クエン酸 PH6.5に調整 水 100%に調整 A成分およびB成分を常法に従つて、各々、
別々に混合して得た2つの液体組成物を重量比
7:3の割合で均一に混合し、室温に1日間保持
して熟成する。上記各成分を用いて本発明組成物
を得た。 実施例 4 第1組成物 タラの肝油 100% 第2組成物 生卵白 100% 第3及び第4組成物の混合物 A 成分 卵黄油 100% B 成分 チオグリコール酸アンモニウム 5% 水酸化ナトリウム PH8.0に調整 水 100%に調整 第5組成物 過酸化水素(6%) 30c.c. サリチル酸 2g 第6組成物 臭素酸カリウム 5% クエン酸 PH6.5に調整 水 100%に調整 B成分を常法に従つて混合し、A成分:B成分
の割合8:2で均一に混合し、室温で1日間保持
して熟成する。上記各成分を用いて本発明組成物
を得た。 つぎに本発明の組成物の脱色効果および皮膚に
対する刺激を試験した結果を示す。 (1) 脱色効果 黒皮症の患者10名に前記実施例1の組成物を1
週間間隔で使用し、その使用前の皮膚着色面積に
対する脱色面積の増加を肉眼で観察し、つぎの評
価に従つて脱色効果を判定した。 脱色効果非常に良好:脱色部80〜100% 脱色効果良好:脱色部50〜80% 脱色効果あり:脱色部20〜50% 脱色効果不良:脱色部20%以下 つぎの第1−A表に判定結果を示す。表中の数
字は対応する脱色効果を示した人数を意味する。
The present invention relates to compositions for skin bleaching and treating skin diseases. Various drugs and compositions have been known for use in bleaching unwanted skin hair, preventing age spots, freckles, sunburn, and the like. For example, hydrogen peroxide is used to bleach unwanted hair, and skin bleaching agents such as hydroquinone are used to prevent age spots, freckles, and sunburn.
Compositions containing vitamin C, vitamin C derivatives, crude drug extracts, etc. are known. However, these drugs and compositions have drawbacks such as being highly irritating to the skin, and conversely, those that are less irritating may take a long time to develop their efficacy or are insufficiently effective. It is difficult to use these to remove spots, freckles, bruises, etc. without irritating the skin. Furthermore, in recent years, skin disorders caused by cosmetics, particularly dark brown skin discoloration due to melasma, have become a major problem, and it is considered to be extremely difficult to remove such skin discoloration. However, the present inventor surprisingly found that by using a three-dose or two-dose composition containing a sulfur-containing compound with a reducing action and certain ingredients, it was found that no harmful irritation was caused to the skin. He discovered that it was possible to remove not only stains and freckles, but also bruises and skin discoloration caused by melasma in a very short period of time without causing irritation or inflammation.
Patent No. 1051060) was obtained. The inventor continued to conduct intensive research, and found that
By adding new ingredients to the above-mentioned patented composition, an even more excellent skin bleaching effect can be obtained, and it can also be used to treat skin diseases such as acne, pimples, mold-like and other eczema, athlete's foot, and skin diseases. The present invention was completed based on the discovery that it is possible to obtain a composition that is also extremely effective. That is, the present invention provides a first composition containing animal liver oil, a basic fourth composition containing a sulfur-containing compound, a fifth composition containing hydrogen peroxide and salicylic acid, and an acidic composition containing bromate. A 4-dose type comprising a sixth composition, and a 5-dose type using a second composition containing raw egg white next to the first composition; Next, the present invention relates to a 6-dose composition for skin bleaching and skin disease treatment using a third composition containing egg yolk oil or a lecithin-oil mixture. In the present invention, it is also advantageous to use the third composition and the fourth composition after being mixed and aged in advance. Although the mechanism of action of the composition of the present invention is not clear, by using the composition of the present invention several times,
It can remove age spots, freckles, birthmarks (especially acquired ones), and skin discoloration caused by melasma without causing any harmful irritation or inflammation to the skin. In particular, the third and fourth aspects of the present invention
A composition prepared by aging the composition in advance causes almost no irritation to the skin, can completely suppress the specific odor of the sulfur-containing compound, and has an extremely good feeling of use. In addition, the composition of the present invention not only has the effect of bleaching the skin, but also has the effect of preventing acne and wrinkles. It is extremely effective against mold-like and other skin diseases that have been considered to be diseases, and is also useful as a therapeutic agent for skin diseases. Various animal liver oils can be used as the essential component of the first composition of the present invention, and fatty oils obtained from the livers of fish such as shark, cod, squid, and whales are particularly preferred. The raw egg white of the second composition is usually preferably raw chicken egg white. The egg yolk oil used as an essential component of the third composition is
Preferred are organic solvent extracts, such as ether extracts of chicken egg yolks, especially ether extracts. The lecithin-oil mixture may also be prepared by combining egg yolk lecithin or soybean lecithin with a vegetable oil such as soybean oil, olive oil, etc., preferably soybean oil, preferably in a lecithin:vegetable oil weight ratio of 30-40:70-60.
It is a mixture as follows. These components may be used alone as the third composition. Additionally, if desired, other ingredients such as olive oil and honey may be added to the third composition, up to a maximum of about 50%
% (weight %, the same applies hereinafter) may be added, thereby improving the feeling of use. Examples of the sulfur-containing compound used as an essential component of the fourth composition include basic salts of mercaptans such as thioglycolic acid, thiolactic acid, thiopropionic acid, thiosalicylic acid, and thiobutyric acid, preferably ammonium thioglycolic acid. Salts, ethylenediamine salts, monoethanolamine salts, diethanolamine salts, triethanolamine salts, etc., bisulfites such as sodium bisulfite, cysteine (including L, D, DL forms), etc.
Particular preference is given to ammonium thioglycolate. These sulfur-containing compounds are usually blended in a proportion of about 1 to 10%, preferably about 3 to 6%, in the fourth composition, and the fourth composition contains, for example, sodium hydroxide, potassium hydroxide, sodium carbonate. , basic using ammonia etc., preferably about 7.5-8.5
Adjust to PH. In the fifth composition, hydrogen peroxide is typically about 1 to 40%
%, especially about 3 to 10%, and commercially available oxidols can be used. The fifth composition is a hydrogen peroxide solution containing salicylic acid of about 0.1 to
It is prepared by dissolving 30%, preferably about 1 to 20%, and it is particularly desirable to prepare it immediately before use. Essential components of the sixth composition include bromates, for example alkali metal bromates such as sodium or potassium bromate, which may be used alone or in admixture, preferably potassium bromate. Use salt. This component is usually blended in the sixth composition at about 10%, preferably about 3 to 6%,
The sixth composition includes, for example, citric acid, oxalic acid,
The pH is adjusted to be acidic, preferably about 5.5 to 6.5, with succinic acid, acetic acid, benzoic acid, etc. Further, in the present invention, the third composition and the fourth composition are uniformly mixed at a weight ratio of 9 to 5:1 to 5, and the mixture is heated at 10 to 30°C, preferably at room temperature. By holding and aging for 1 to 3 days, preferably about 1 day, the characteristic odor of the sulfur-containing compound can be suppressed and the usability can be improved without affecting the effect at all. To give one preferred example of applying the composition of the present invention, first, the first composition is applied to a colored part of the skin or a part to be treated, rubbed in, and then treated with the second composition in the same manner. Thereafter, the third composition is applied and pine surge is performed, and then the fourth composition is taken on cotton gauze, etc., applied by dabbing, pine surge is performed, and after being left for several minutes, it is wiped off. Even when a mixture of the third composition and the fourth composition is used, pine surge is performed after application, and the mixture is left for several minutes and then wiped off. Next, the fifth composition is applied, and after being left for a while, the sixth composition is finally treated in the same manner as the fourth composition. Thus, any of the compositions of the invention may be mixed,
They can be formulated into dosage forms such as solutions, emulsions, gels, creams, aerosols, etc. by conventional methods such as dissolution. Next, the present invention will be explained in more detail with reference to Examples. Example 1 First composition Shark liver oil 100% Fourth composition Ammonium thioglycolate 5% Sodium hydroxide Adjusted to PH8.0 Water Adjusted to 100% Fifth composition Hydrogen peroxide (6%) 20c.c. Salicylic acid 2g Sixth composition Potassium bromate 5% Citric acid Adjusted to PH6.5 Water Adjusted to 100% A composition of the present invention was obtained using each of the above components. Example 2 First composition Shark liver oil 100% Second composition Raw egg white 100% Fourth composition Ammonium thioglycolate 3% Sodium hydroxide Adjusted to PH8.0 Water Adjusted to 100% Fifth composition Hydrogen peroxide (6%) 10c.c. Salicylic acid 1.5g Sixth composition Potassium bromate 3% Citric acid Adjusted to PH6.5 Water Adjusted to 100% A composition of the present invention was obtained using the above components. Example 3 First composition Shark liver oil 100% Second composition Raw egg white 100% Mixture A of third and fourth compositions Ingredients Soybean lecithin-soybean oil (1:1 mixture by weight)
85% Olive oil 10% Honey 5% B Ingredients Ammonium thioglycolate 5% Sodium hydroxide Adjusted to PH8.0 Water Adjusted to 100% Fifth composition Hydrogen peroxide (6%) 25cc. Salicylic acid 3g Sixth composition Potassium bromate 5% Citric acid Adjusted to PH6.5 Water Adjusted to 100% Component A and B were each added according to the usual method.
The two liquid compositions obtained by mixing separately are mixed uniformly at a weight ratio of 7:3 and kept at room temperature for one day to age. A composition of the present invention was obtained using each of the above components. Example 4 First composition Cod liver oil 100% Second composition Raw egg white 100% Mixture of third and fourth compositions A Component Egg yolk oil 100% B Component Ammonium thioglycolate 5% Sodium hydroxide pH 8.0 Adjustment Water Adjusted to 100% 5th composition Hydrogen peroxide (6%) 30cc. Salicylic acid 2g 6th composition Potassium bromate 5% Citric acid Adjusted to PH6.5 Water Adjusted to 100% Component B in the usual manner Therefore, they are mixed uniformly at a ratio of 8:2 of component A: component B, and kept at room temperature for one day to ripen. A composition of the present invention was obtained using each of the above components. Next, the results of testing the bleaching effect and skin irritation of the composition of the present invention are shown. (1) Depigmentation effect One dose of the composition of Example 1 was given to 10 melasma patients.
The product was used at weekly intervals, and the increase in the bleached area relative to the skin colored area before use was visually observed, and the bleaching effect was determined according to the following evaluation. Very good bleaching effect: 80-100% bleached area Good bleaching effect: 50-80% bleached area Good bleaching effect: 20-50% bleached area Poor bleaching effect: 20% or less bleached area Judgment as shown in Table 1-A below Show the results. The numbers in the table mean the number of people who showed the corresponding bleaching effect.

【表】 次に実施例3の組成物を用いて同様に脱色効果
を判定し、その結果を第1−B表に示す。
[Table] Next, the decolorizing effect was determined in the same manner using the composition of Example 3, and the results are shown in Table 1-B.

【表】 (2) 皮膚に対する刺激 黒皮症の患者10名に、前記実施例1の組成物、
前記実施例4の組成物および対照として前記実施
例1の組成物から第1組成物を除いたものを用
い、皮膚に適用した場合の刺激および臭いについ
て感応試験した。結果をつぎの第2表に示す。表
中の数字は人数を意味する。
[Table] (2) Skin irritation The composition of Example 1,
The composition of Example 4 and the composition of Example 1 except for the first composition as a control were used to conduct sensitivity tests for irritation and odor when applied to the skin. The results are shown in Table 2 below. The numbers in the table mean the number of people.

【表】 この結果から明らかなごとく、本発明の組成物
は皮膚に対して有害な刺激を与えることもなく、
含硫黄化合物の硫黄臭が抑制され、使用感が優れ
ている。 実施例 5 バニシング・クリームタイプの組成物 ベース処方 ミツロウ 2.5% ステアリン酸 8.0% セタノール 3.0% ラノリン 1.0% I.P.M 5.0% 流動パラフイン 10.5% ポリオキシエチレンソルビタンモノステア
レート 4.0% ソルビタンモノラウレート 1.0% トリエタノールアミン 0.5% グリセリン 4.0% 水 100%に調整 常法に従つてこの処方によりクリームベースを
調製する。 第3及び第4組成物の混合物 A 成分 大豆レシチン−大豆油(重量比1:1)
85% オリーブ油 10% ハチミツ 5% B 成分 チオグリコール酸アンモニウム 5% 水酸化ナトリウム PH8.0に調整 水 100%に調整 前記実施例3と同様にA成分およびB成分を別
別に混合し、これらの成分を順次、前記で得られ
たベースに添加し(A:B=7:3)、均一に混
合した後、1日室温に保持熟成して混合組成物を
得る。 上記混合組成物を使用した以外は実施例3と同
様にして、バニシング・クリームタイプの組成物
を得た。 次に本発明の組成物の皮膚疾患治療効果につい
て試験した結果を示す。 (1) ニキビ吹出物の治療効果 年令25才の女性の顔に発生したニキビに対して
実施例1の組成物を用いて治療したところ、表面
の化膿がなくなり、更に第2回目の処理を行うと
内部のしこりが消えた。またこの間、第1〜2回
目の治療の間にできたニキビも消失した。第3回
目の治療によりニキビはほぼ完全に治愈され、第
4回目からはニキビ跡のシミの除去が行われた。 (2) 水虫の治療効果 水虫についても上記ニキビの場合と同様にして
3〜4回で完治した。 (3) カビ様の皮膚病治療効果 年令50才の男性の全身に発生したカビ様の皮膚
病が長年各種の方法で治療を試みたが治らなかつ
たが、本発明の実施例3の組成物を用いて治療を
行つたところ約6回でほぼ完治した。
[Table] As is clear from the results, the composition of the present invention does not cause harmful irritation to the skin;
The sulfur odor of sulfur-containing compounds is suppressed and the usability is excellent. Example 5 Vanishing cream type composition base formulation Beeswax 2.5% Stearic acid 8.0% Setanol 3.0% Lanolin 1.0% IPM 5.0% Liquid paraffin 10.5% Polyoxyethylene sorbitan monostearate 4.0% Sorbitan monolaurate 1.0% Triethanolamine 0.5% Glycerin 4.0% Water Adjust to 100% A cream base is prepared using this recipe according to a conventional method. Mixture A of third and fourth compositions Ingredients Soybean lecithin-soybean oil (weight ratio 1:1)
85% Olive oil 10% Honey 5% B Component Ammonium thioglycolate 5% Sodium hydroxide Adjusted to PH8.0 Water Adjusted to 100% As in Example 3, component A and component B were mixed separately, and these components were mixed separately. were sequentially added to the base obtained above (A:B=7:3), mixed uniformly, and then aged at room temperature for one day to obtain a mixed composition. A vanishing cream type composition was obtained in the same manner as in Example 3 except that the above mixed composition was used. Next, the results of testing the therapeutic effect of the composition of the present invention on skin diseases will be shown. (1) Treatment effect for acne breakouts When the composition of Example 1 was used to treat acne that appeared on the face of a 25-year-old woman, the surface suppuration disappeared, and a second treatment was performed. The lump inside disappeared. During this time, the acne that appeared during the first and second treatments also disappeared. After the third treatment, the acne was almost completely cured, and from the fourth treatment, the acne scars were removed. (2) Treatment effect for athlete's foot The athlete's foot was completely cured in 3 to 4 treatments in the same way as for acne. (3) Effect on the treatment of mold-like skin disease The mold-like skin disease that occurred all over the body of a 50-year-old man had been tried for many years by various methods, but it was not cured, but the composition of Example 3 of the present invention When the patient received medical treatment, he was almost completely cured after about 6 treatments.

Claims (1)

【特許請求の範囲】 1 動物性肝油を含有する第1組成物、含硫黄化
合物を含有する塩基性の第4組成物、過酸化水素
及びサリチル酸を含有する第5組成物並びに臭素
酸塩を含有する酸性の第6組成物からなることを
特徴とする4剤型の皮膚脱色及び皮膚疾患治療用
組成物。 2 動物性肝油を含有する第1組成物、生卵白を
含有する第2組成物、含硫黄化合物を含有する塩
基性の第4組成物、過酸化水素及びサリチル酸を
含有する第5組成物並びに臭素酸塩を含有する酸
性の第6組成物からなることを特徴とする5剤型
の皮膚脱色及び皮膚疾患治療用組成物。 3 動物性肝油を含有する第1組成物、生卵白を
含有する第2組成物、卵黄油又はレシチン−油混
合物を含有する第3組成物、含硫黄化合物を含有
する塩基性の第4組成物あるいはこれら第3およ
び第4の2つの組成物の混合物、過酸化水素及び
サリチル酸を含有する第5組成物並びに臭素酸塩
を含有する酸性の第6組成物からなることを特徴
とする6剤型又は5剤型の皮膚脱色及び皮膚疾患
治療用組成物。 4 第3組成物のレシチン−油混合物がレシチ
ン:植物油の重量比が30〜40:70〜60の混合物で
ある請求の範囲第3項の組成物。 5 第4組成物の含硫黄化合物がチオグリコール
酸の塩基性塩、チオ乳酸の塩基性塩、チオプロピ
オン酸の塩基性塩、チオサリチル酸の塩基性塩、
チオ酪酸の塩基性塩、重亜硫酸塩又はシステイン
である請求の範囲第1〜3項のいずれかに記載の
組成物。 6 第4組成物のPHが約7.5〜8.5である請求の範
囲第1〜3項のいずれかに記載の組成物。 7 第6組成物の臭素酸塩が臭素酸のアルカリ金
属塩である請求の範囲第1〜3項のいずれかに記
載の組成物。 8 第6組成物のPHが約5.5〜6.5である請求の範
囲第1〜3項のいずれかに記載の組成物。
[Claims] 1. A first composition containing animal liver oil, a basic fourth composition containing a sulfur-containing compound, a fifth composition containing hydrogen peroxide and salicylic acid, and a bromate salt. A 4-dose composition for skin bleaching and skin disease treatment, characterized by comprising an acidic sixth composition. 2. A first composition containing animal liver oil, a second composition containing raw egg white, a basic fourth composition containing a sulfur-containing compound, a fifth composition containing hydrogen peroxide and salicylic acid, and bromine. A 5-dose composition for skin bleaching and skin disease treatment, characterized by comprising an acidic sixth composition containing an acid salt. 3. A first composition containing animal liver oil, a second composition containing raw egg white, a third composition containing egg yolk oil or a lecithin-oil mixture, and a basic fourth composition containing a sulfur-containing compound. Alternatively, a six-dose form comprising a mixture of these third and fourth two compositions, a fifth composition containing hydrogen peroxide and salicylic acid, and an acidic sixth composition containing bromate. Or a 5-dose composition for skin bleaching and skin disease treatment. 4. The composition of claim 3, wherein the lecithin-oil mixture of the third composition is a mixture of lecithin:vegetable oil in a weight ratio of 30-40:70-60. 5 The sulfur-containing compound of the fourth composition is a basic salt of thioglycolic acid, a basic salt of thiolactic acid, a basic salt of thiopropionic acid, a basic salt of thiosalicylic acid,
The composition according to any one of claims 1 to 3, which is a basic salt, bisulfite, or cysteine of thiobutyric acid. 6. The composition according to any one of claims 1 to 3, wherein the fourth composition has a pH of about 7.5 to 8.5. 7. The composition according to any one of claims 1 to 3, wherein the bromate of the sixth composition is an alkali metal salt of bromate. 8. The composition according to any one of claims 1 to 3, wherein the sixth composition has a pH of about 5.5 to 6.5.
JP57082137A 1982-05-14 1982-05-14 Composition for decoloring skin and treating skin disease Granted JPS58198421A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57082137A JPS58198421A (en) 1982-05-14 1982-05-14 Composition for decoloring skin and treating skin disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57082137A JPS58198421A (en) 1982-05-14 1982-05-14 Composition for decoloring skin and treating skin disease

Publications (2)

Publication Number Publication Date
JPS58198421A JPS58198421A (en) 1983-11-18
JPS649965B2 true JPS649965B2 (en) 1989-02-21

Family

ID=13766026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57082137A Granted JPS58198421A (en) 1982-05-14 1982-05-14 Composition for decoloring skin and treating skin disease

Country Status (1)

Country Link
JP (1) JPS58198421A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6322507A (en) * 1986-07-14 1988-01-30 Shiseido Co Ltd External preparation for skin
GB9218701D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Housewife dermatitis treatment
GB9218771D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Synergistic composition for dermatitis treatment
FR2751537B1 (en) * 1996-07-26 2004-04-16 Oreal USE OF HONEY AS A KERATOLYTIC AGENT, PARTICULARLY FOR IMPROVING THE RADIANCE OF THE SKIN AND TREATING WRINKLES
IT1291622B1 (en) * 1997-04-18 1999-01-11 Marcello Izzo USE OF THIOGLYCOLIC ACID AS A DEPIGMENTING AGENT
FR2804862B1 (en) * 2000-02-10 2002-06-07 Fabre Pierre Dermo Cosmetique COSMETIC COMPOSITIONS BASED ON THIOSALICYL DERIVATIVES AND NOVEL THINOSALICYL DERIVATIVES OF THE QUINOLYL TYPE
AU2004271775A1 (en) * 2003-09-13 2005-03-24 Reckitt & Colman Overseas Limited Skincare compositions comprising salicyclic acid
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20080038299A1 (en) * 2004-02-19 2008-02-14 Reckitt & Colman (Overseas) Limited Skincare Compositions Comprising Salicylic Acid

Also Published As

Publication number Publication date
JPS58198421A (en) 1983-11-18

Similar Documents

Publication Publication Date Title
JPS59500129A (en) Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant
US20110236503A1 (en) Topical Skincare Composition
JPS649965B2 (en)
JP3995720B2 (en) Cosmetic body care preparation and process for its production
JPH08507044A (en) Hair treatment composition
JPH0558851A (en) Trichogenous and hair-growing agent
EP3781152B1 (en) Topical formulations comprising strontium and methylsulfonylmethane (msm) and their use for skin treatment
JPS6360910A (en) Skin drug for external use
JPH11269034A (en) Skin prepafation for external use for improving acne
DE19818849A1 (en) Formulation to promote deep skin penetration
JPS61176510A (en) Skin-beautifying cosmetic
JPH11269043A (en) Cosmetic for scalp and hair
JPH03200708A (en) Dermal external agent
JP2017193503A (en) Deodorizing cosmetic
JPS6322510A (en) External preparation for skin
JP2017193504A (en) Deodorizing cosmetic
CN106580870A (en) Gel for treating acne and preparation method for gel
JP3115445B2 (en) Whitening cosmetics
JP2002332237A (en) Skin care preparation
KR0153203B1 (en) Cosmetic composition for moisturising and softening
JPS5883612A (en) Deodorant and sweatproof coating agent
KR20070065960A (en) COSMETIC COMPOSITION COMPRISING alpha;-HYDROXY ACID AND ETHER SURFACTANT
JPS6360935A (en) Sebum suppressive agent
JP2003160457A (en) Prophylactic and therapeutic agent for dentin hypersensitivity
JPH0425250B2 (en)